Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Heloisa Westphalen"'
Publikováno v:
Biomedical Engineering Advances, Vol 6, Iss , Pp 100104- (2023)
Protein adsorption on hemodialysis (HD) membrane matrices and surfaces is a highly undesirable process, as it triggers complement activation and leads to severe health complications for HD patients. However, there is a lack of systematic research inv
Externí odkaz:
https://doaj.org/article/a768ab01def14a30aa526c910e8fe4de
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Abstract Chronic kidney disease affects millions of people around the globe and many patients rely on hemodialysis (HD) to survive. HD is associated with undesired life-threatening side effects that are linked to membrane biocompatibility and clinica
Externí odkaz:
https://doaj.org/article/a2b0c4cdabee47508c9ec1c7a9a8ffca
Publikováno v:
Biomedical Engineering Advances, Vol 2, Iss , Pp 100021- (2021)
Adsorption of blood proteins during hemodialysis (HD) triggers activation of biochemical cascades and reduces treatment efficacy due to membrane fouling. Complement and coagulation cascades lead HD patients into an inflammatory state that can negativ
Externí odkaz:
https://doaj.org/article/cc2cc3202cfb41d291397da431c02e43
Autor:
Heloisa Westphalen, Phillip Choi, Ahmed Shoker, Shaghayegh Saadati, Amira Abdelrasoul, Huu Doan, Ubong Eduok, Farhad Ein-Mozaffari
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-18 (2020)
Scientific Reports
Scientific Reports
End stage renal disease (ESRD) patients depend on hemodialysis (HD) as a life-sustaining treatment, but HD membrane properties play a critical role in blood activation during HD and can lead to severe patient outcomes. This study reports on a series
Autor:
Heloisa Westphalen, Shaghayegh Saadati, Jumanah Bahig, Huu Doan, Ahmed Shoker, Amira Abdelrasoul
Publikováno v:
Journal of Composites Science; Volume 6; Issue 8; Pages: 226
Hemodialysis (HD) is a life-sustaining treatment of crucial importance in managing end-stage renal disease (ESRD). However, this membrane-based therapy is associated with acute side-effects due to bioincompatibility issues and limitations on the remo
Autor:
Ubong Eduok, Farhad Ein-Mozaffari, Ning Zhu, Shaghayegh Saadati, Ahmed Shoker, Amira Abdelrasoul, Huu Doan, Heloisa Westphalen, Phillip Choi
Publikováno v:
Materials scienceengineering. C, Materials for biological applications. 117
The aim of the current research study is to conduct a comparative assessment of biocompatibility of zwitterionic-coated polyether sulfone (PES) clinical hemodialysis (HD) membranes using both theoretical and experimental methods. Fibrinogen plays a k
Autor:
Farhad Ein-Mozaffari, Amira Abdelrasoul, Ubong Eduok, Huu Doan, Ahmed Shoker, Ning Zhu, Heloisa Westphalen, Phillip Choi, Shaghayegh Saadati
Publikováno v:
Surfaces and Interfaces. 27:101505
Hemodialysis (HD) treatment leads to biochemical cascades due to protein adsorption and interactions, resulting in life-threatening side effects in many patients. Hemodialysis polyvinylidene fluoride (PVDF) membranes, independent of their structures
Autor:
Heloisa Westphalen, Huu Doan, Ubong Eduok, Phillip Choi, Ahmed Shoker, Farhad Ein-Mozaffari, Shaghayegh Saadati, Amira Abdelrasoul, Ning Zhu
Publikováno v:
Materials Today Communications. 29:102928
While hemodialysis augments the physiological functions of the kidney in end stage renal disease (ESRD) patients, inherent membrane properties initiate life-threating biological episodes upon contact with blood. Membrane materials have different morp
Publikováno v:
Separation and Purification Technology. 259:118136
Protein adsorption in highly undesirable in hemodialysis (HD) since it leads to activation biochemical cascades and membrane fouling. The present study aims to obtain an in-depth understanding of the influence of clinical practice on in-vitro adsorpt
Publikováno v:
Colloid and Interface Science Communications. 40:100348
Kidney failure affects a significant part of the world's population where more than 2 million people currently undergoing some sort of treatment for end-stage kidney disease (ESKD). One of the most common treatments is hemodialysis (HD) which consist